Cartography Biosciences
South San Francisco
About Cartography Biosciences
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens. The company provides a differentiated oncology pipeline of antibody-based therapies to target tumors more precisely than existing therapeutics. Its ATLAS and SUMMIT drug discovery platforms are powered by an industry-leading, fully integrated dataset spanning hundreds of thousands of cell states across the healthy body and large-scale profiling of individual cells from patient tumors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $124.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2025)
- Website: cartography.bio
- Phone: 833-318-4749
Industries & Categories
Biopharma, Biotechnology, Life Science, Oncology
Social Profiles
Canonical: https://fsome.com/organization/cartography-biosciences-26015 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.